Coronavirus vaccine update: UK plans to infect volunteers with COVID-19; AstraZeneca US trials to resume

Coronavirus vaccine update: UK plans to infect volunteers with COVID-19; AstraZeneca US trials to resume

Coronavirus vaccine news: Britain will help fund trials using a manufactured COVID-19 virus to deliberately infect young healthy volunteers with the hope of accelerating the development of vaccines against it

Advertisement
Coronaviru vaccine update:  AstraZeneca's COVID-19 vaccine trial in the US is likely to resume as early as this week after the FDA completed its review of a serious illness in a study participantCoronaviru vaccine update: AstraZeneca's COVID-19 vaccine trial in the US is likely to resume as early as this week after the FDA completed its review of a serious illness in a study participant
BusinessToday.In
  • Oct 21, 2020,
  • Updated Oct 21, 2020 10:49 AM IST

Coronavirus vaccine update: The British government will fund clinical trials to purposely infect study participants with COVID-19 to fastrack the coronavirus vaccine research.

The tests called "human challenge" trials will be conducted by researchers to infect young and healthy volunteers with SARS-CoV-2, the virus that causes COVID-19. In another development, the AstraZeneca-Oxford coronavirus vaccine trials are likely to resume again after halting them, as one of the study participants in the UK developed an "unexplained illness" following an adverse event. Meanwhile, the health ministry in India has identified three crore healthcare workers who will be vaccinated in the first round. This comprised approximately 80 lakh doctors and around 2 crore other essential workers.

Advertisement

Also Read:

Coronavirus vaccine update: The British government will fund clinical trials to purposely infect study participants with COVID-19 to fastrack the coronavirus vaccine research.

The tests called "human challenge" trials will be conducted by researchers to infect young and healthy volunteers with SARS-CoV-2, the virus that causes COVID-19. In another development, the AstraZeneca-Oxford coronavirus vaccine trials are likely to resume again after halting them, as one of the study participants in the UK developed an "unexplained illness" following an adverse event. Meanwhile, the health ministry in India has identified three crore healthcare workers who will be vaccinated in the first round. This comprised approximately 80 lakh doctors and around 2 crore other essential workers.

Advertisement

Also Read:

Read more!
Advertisement